|
Adherence enhancing program for patients with metastatic, castration-resistant prostate carcinoma treated with abiraterone acetate plus prednisone: A cluster randomized trial. |
|
|
Honoraria - Astellas Pharma; Astellas Pharma; Astellas Pharma; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Medac; Medac; Medac; MSD; MSD; MSD; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Takeda; Takeda; Takeda |
Consulting or Advisory Role - Astellas Oncology; Astellas Oncology; Astellas Oncology; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Medac; Medac; Medac; MSD; MSD; MSD; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Takeda; Takeda; Takeda |
Research Funding - Astellas Oncology; Astellas Oncology; Astellas Oncology; Janssen; Janssen |
Travel, Accommodations, Expenses - Astellas Medivation; Astellas Medivation; Astellas Medivation; Bayer; Bayer; Bayer; Ipsen; Ipsen; Ipsen; Janssen; Janssen; Janssen; Medac; Medac; Medac; MSD; MSD; MSD; Sanofi/Aventis; Sanofi/Aventis; Sanofi/Aventis; Takeda; Takeda; Takeda |
|
|
No Relationships to Disclose |
|
|
|
Travel, Accommodations, Expenses - Janssen |
|
|
Consulting or Advisory Role - Astellas Oncology |
Research Funding - Astellas Oncology; Bristol-Myers Squibb; Inc Research; Janssen; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Janssen-Cilag |
|
|
Employment - Janssen-Cilag |